DD-CIP2

DD-CIP2 is a DNA damage inducer that triggers significant DNA damage, cell cycle arrest, and apoptosis by modulating DNA damage response pathways. It demonstrates notable antitumor efficacy without apparent toxicity at well-tolerated doses in vivo. Its exceptional cytotoxicity against a range of cancer cell lines from hematological and solid tumors is independent of their BRCA1/2 status. DD-CIP2 can be utilized in research on small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) .